COLLEGIUM PHARMACEUTICAL, INC (COLL) › Cost of RevenueCOLLEGIUM PHARMACEUTICAL, INC (COLL) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2016: $213.0K2017: $2.60M2018: $165.68M2019: $193.66M2020: $130.18M2021: $126.25M2022: $254.44M2023: $240.60M2024: $254.10M2025: $317.31M$317.31M2016Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$317.31M+24.9%2024$254.10M+5.6%2023$240.60M-5.4%2022$254.44M+101.5%2021$126.25M-3.0%2020$130.18M-32.8%2019$193.66M+16.9%2018$165.68M+6284.5%2017$2.60M+1118.3%2016$213.0K—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share